Mylan Initiaties Voluntary Nationwide Recall of Select Lots of Injectable Products, Including Methotrexate

Article Type: 
Blog

Mylan Initiaties Voluntary Nationwide Recall of Select Lots of Injectable Products, Including Methotrexate

As part of the CreakyJoints community, we value your health and safety. Below please find information that we received regarding a voluntary recall of Methotrexate. If you have the affected lot number, alert your pharmacist and prescriber immediately, and please let us know you were affected by emailing us at upthecreak@creakyjoints.org<mailto:upthecreak@creakyjoints.org?subject=Affected%20by%20Methotrexate%20Recall>.

On April 23, 2015, U.S.-based Mylan Institutional conducted a voluntary nationwide recall of the following injectable products, including Methotrexate, due to "the presence of visible foreign particulate matter observed during testing of retention samples."

Click here to read the full press release on our website.<http://creakyjoints.us8.list-manage1.com/track/click?u=9d2bc7b86ce2e776e067d6fbc&id=08127c09c1&e=60c14b06c9>

NDC Number
Product Name and Strength
Size
Lot Number
Expiration Date
67457-464-20

Gemcitabine for Injection, USP 200mg
10 mL
7801396
08/2016
67457-464-20

Gemcitabine for Injection, USP 200mg
10 mL
7801401
08/2016
0069-3857-10

Gemcitabine for Injection, USP 200mg
10 mL
7801089
07/2015
67457-463-02

Gemcitabine for Injection, USP 2 g
100 mL
7801222
03/2016
67457-462-01

Gemcitabine for Injection, USP 1 g
50 mL
7801273
05/2016
67457-493-46

Carboplatin Injection 10mg/mL
100 mL
7801312
06/2015
0069-0146-02

Methotrexate Injection, USP 25mg/mL
2 mL (5 x 2mL)
7801082
07/2015
0069-0152-02

Cytarabine Injection 20mg/mL
5 mL (10 x 5mL)
7801050
05/2015